General Info

Regeneron Pharmaceuticals is a biopharmaceutical company engaged in discovering, developing and eventually commercializing therapeutic medicines for the treatment of medical conditions, such as eye disease, cancer and inflammation. Regeneron s platform technologies are designed to understand the biology of specific disease states, discover potential therapeutic candidates and evaluate these candidates in clinical trials. Regeneron s therapeutic candidates are in clinical trials for the potential treatment of obesity, rheumatoid arthritis and cancer. The company also maintains preclinical programs in asthma, allergies and other diseases and disorders. Founded in 1988, the company continues to develop and commercialize therapeutic agents to treat unmet medical needs. Regeneron Pharmaceuticals maintains its corporate office in Tarrytown, N.Y., as well as a manufacturing facility in Rensselaer, N.Y.